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Dear Editor
The present letter concerns anti-cancer natural 
products inducing cross-talk between apoptosis and 
autophagy mutual proteins to regulate cancer cell death 
for future cancer green therapeutic approaches. The course 
of cancer advancement has always been attributed to the 
defectiveness in cell death mechanisms (Du et al., 2013; 
Hematulin et al., 2014). These defects act as a shield in 
protecting tumor cells from drugs and therapies, all at the 
same time, maintaining a longer life span and prompting 
their dispersion procedures. Autophagy and apoptosis 
safeguards cells from cellular damages and maintains 
proliferation and homeostasis by deporting outgrowth 
and controlling differentiation of pernicious cells. The 
autophagic proteins are conventionally found in hindering 
apoptosis whereas vice versa accounts had been reported 
for apoptotic-intermediates in preventing autophagic 
responses. 
Under specific conditions, autophagy and apoptosis 
can be instigated in a congruous or interdependent 
manner through manipulation of their mutual proteins. 
Targeting those mutual proteins that crosstalk between 
autophagy and apoptosis to regulate tumor cell death 
is crucial for the successful design of future anticancer 
therapies. To counterbalance, microRNA (miRNA) are 
required in modulating the expression of these interplaying 
components that may set off both autophagy and apoptosis 
in cancer cells. However, critical drawbacks in the 
development of miRNA-based therapeutic alone seem 
laborious and a long drawn out story. 
Resolving these gaps, we suggests that we need to 
target and focuses on the green chemopreventive agents, 
also known as natural medicinal plants which is rich in 
dietary pyhtochemicals with various medicinal properties 
and accepted for their miraculous action in managing 
malignance of cancer cells. Interestingly, almost all the 
literature refers to the property of natural products in 
inducing autophagy and apoptosis in cancer (Safarzadeh 
et al., 2014; Wang and Feng, 2015).  Moreover, a number 
of natural agents capable of switching these interplaying 
proteins to maximize cancer cell death through the 
partnership of autophagy and apoptosis have been reported 
(Delmas et al., 2011; Xu et al., 2013). By doing so, we will 
be able to chart the missing links between these machinery 
proteins, green chemopreventive agents and miRNAs. The 
role of green natural chemopreventive agents in autophagy 
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and apoptosis will expand the existing knowledge on 
miRNAs hence construct a devising road to a tactical 
anti-cancer therapy with minimized adverse effects. As 
natural products are an essential source in discovery of 
lead compounds of anticancer drug, studies on the role 
of natural product anti-cancer agents that induce cross-
talk between apoptosis and autophagy mutual proteins 
to regulate cancer cell death as a design of future green 
anticancer therapies continue to be necessary.
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